PRL3-zumab as an anti-angiogenic therapy in neovascular eye diseases

Journal:

Nature Communications

Published:

2025-05-23

DOI:

10.1038/s41467-025-59929-2

Affiliations:

6

Authors:

13

Go to article

Institutions	Authors	Share
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore	9.083333	0.70
Singapore Eye Research Institute (SERI), SNEC, Singapore	1.583333	0.12
Duke-NUS Medical School, Singapore	1.333333	0.10
National University of Singapore (NUS), Singapore	0.750000	0.06
NUS National University Hospital (NUH), Singapore	0.250000	0.02

Interested in Ophthalmology and Optometry?